Publications

Publications

Pertsinidou, E., Salomon, B., Bergemalm, D., Salihovic, S., Hedin, C. R. H., Lundström, M. L., Keita, Å. V., Magnusson, M. K., Eriksson, C., Bengtson, M.-B., Høivik, M. L., Söderholm, J. D., Halfvarson, J. Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype. Journal of Crohn’s & Colitis, 19(5), jjaf062. https://doi.org/10.1093/ecco-jcc/jjaf062
 

Samira Salihovic, Niklas Nyström, Charlotte Bache-Wiig Mathisen, Robert Kruse, Christine Olbjørn, Svend Andersen, Alexandra J. Noble, Maria Dorn-Rasmussen, Igor Bazov, Gøri Perminow, Randi Opheim, Trond Espen Detlie, Gert Huppertz-Hauss, Charlotte R. H. Hedin, Marie Carlson, Lena Öhman, Maria K. Magnusson, Åsa V. Keita, Johan D. Söderholm, Mauro D'Amato, Matej Orešič, Vibeke Wewer, Jack Satsangi, Carl Mårten Lindqvist, Johan Burisch, Holm H. Uhlig, Dirk Repsilber, Tuulia Hyötyläinen, Marte Lie Høivik & Jonas Halfvarson. Identification and validation of a blood-based diagnostic lipidomic signature of pediatric inflammatory bowel disease Nat Commun. 2024 Jun 3;15(1):4567. https://doi: 10.1038/s41467-024-48763-7
 

Rejler, M., Füchtbauer, J. D., Davíðsdóttir, L. G., Fejrskov, A., Söderholm, J. D., Christensen, R., Mortensen, J. H., Jensen, M. D., Høivik, M. L., Repsilber, D., Aalykke, C., Kjeldsen, J., Andersen, V., Halfvarson, J. (2024). Nordic inflammatory bowel disease treatment strategy trial: protocol for the NORDTREAT randomised controlled biomarker-strategy trial. BMJ Open, 14(7), e083163. https://doi.org/10.1136/bmjopen-2023-083163
 

Fejrskov, A., Füchtbauer, J. D., Davíðsdóttir, L. G., Halfvarson, J., Høivik, M. L., Jensen, M. D., Mortensen, J. H., Nielsen, L. N., Rejler, M., Repsilber, D., Söderholm, J. D., Aalykke, C., Andersen, V., Christensen, R., Kjeldsen, J. (2024). Novel biomarker profiles to improve individual diagnosis and prognosis in patients with suspected inflammatory bowel disease: protocol for the Nordic inception cohort study (NORDTREAT). BMJ Open, 14(5), e083144. https://doi.org/10.1136/bmjopen-2023-083144
 

Andersen V, Pingel J, Søfelt HL, Hikmat Z, Johansson M, Pedersen VS, Bertelsen B, Carlsson A, Lindh M, Svavarsdóttir E, Repsilber D, Joergensen MT, Christensen R, Fejrskov A, Füchtbauer JD, Kjeldsen J, Jensen MD, Aalykke C, Rejler M, Høivik ML, Davidsdottir L, Carlson M, Halfvarson J, Zachariassen HH, Petersen LB, Myers ES. Sex and gender in inflammatory bowel disease outcomes and research. Lancet Gastroenterol Hepatol. 2024 Nov;9(11):1041-1051. https://doi: 10.1016/S2468-1253(24)00159-6
 

Hansen S.H., Maseng M.G., Grännö O, Vestergaard M.V., Bang C, Olsen B.C., Lund C., Olbjørn C., Løvlund E.E., Vikskjold F.B., Huppertz-Hauss G., Perminow G., Yassin H., Valeur J., Aass Holten K.I., Henriksen M., Bengtson M.B., Ricanek P., Opheim R., Boyar R., Torp R., Frigstad S.O., Aabrekk T.B., Detlie T.E., Kristensen V.A., Strande V., Hovde Ø., Asak Ø., Jess T., Franke A., Halfvarson J., Høivik M.L., Hov J.R. Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort. Inflamm Bowel Dis. 2025 Aug 1;31(8):2066-2080. doi: 10.1093/ibd/izaf060.

 

Theses

Fejrskov, A. (2025). Biomarkers of connective tissue turnover in inflammatory bowel disease – diagnostic and predictive capacity. PhD Thesis, defended 7th of March 2025.

Füchtbauer, J. D. (2025). The treatment-naïve mycobiome in new-onset inflammatory bowel disease. PhD Thesis, submitted 2025. PhD Thesis, defended 2nd of October 2025.